Literature DB >> 33375363

The Dual Role of Autophagy in Cancer Development and a Therapeutic Strategy for Cancer by Targeting Autophagy.

Chul Won Yun1, Juhee Jeon1, Gyeongyun Go2, Jun Hee Lee3,4,5,6, Sang Hun Lee1,2,7,8.   

Abstract

Autophagy is a delicate intracellular degradation process that occurs due to diverse stressful conditions, including the accumulation of damaged proteins and organelles as well as nutrient deprivation. The mechanism of autophagy is initiated by the creation of autophagosomes, which capture and encapsulate abnormal components. Afterward, autophagosomes assemble with lysosomes to recycle or remove degradative cargo. The regulation of autophagy has bipolar roles in cancer suppression and promotion in diverse cancers. Furthermore, autophagy modulates the features of tumorigenesis, cancer metastasis, cancer stem cells, and drug resistance against anticancer agents. Some autophagy regulators are used to modulate autophagy for anticancer therapy but the dual roles of autophagy limit their application in anticancer therapy, and present as the main reason for therapy failure. In this review, we summarize the mechanisms of autophagy, tumorigenesis, metastasis, cancer stem cells, and resistance against anticancer agents. Finally, we discuss whether targeting autophagy is a promising and effective therapeutic strategy in anticancer therapy.

Entities:  

Keywords:  autophagy; autophagy modulators; cancer; cancer stem cells; drug resistance; metastasis; tumorigenesis

Year:  2020        PMID: 33375363     DOI: 10.3390/ijms22010179

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  17 in total

Review 1.  How Should the Worldwide Knowledge of Traditional Cancer Healing Be Integrated with Herbs and Mushrooms into Modern Molecular Pharmacology?

Authors:  Yulia Kirdeeva; Olga Fedorova; Alexandra Daks; Nikolai Barlev; Oleg Shuvalov
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-14

Review 2.  Regulated cell death (RCD) in cancer: key pathways and targeted therapies.

Authors:  Fu Peng; Minru Liao; Rui Qin; Shiou Zhu; Cheng Peng; Leilei Fu; Yi Chen; Bo Han
Journal:  Signal Transduct Target Ther       Date:  2022-08-13

Review 3.  Tumour Stem Cells in Breast Cancer.

Authors:  Marina Ibragimova; Matvey Tsyganov; Nikolai Litviakov
Journal:  Int J Mol Sci       Date:  2022-05-02       Impact factor: 6.208

4.  Photothermal effect of albumin-modified gold nanorods diminished neuroblastoma cancer stem cells dynamic growth by modulating autophagy.

Authors:  Farhad Bani; Amir Zarebkohan; Reza Rahbarghazi; Zahra Alizadeh Shahabad; Cigir Biray Avci; Majid Sadeghizadeh; Roya Salehi; Maryam Ghafarkhani; Bakiye Goker Bagca; Neslihan Pınar Ozates
Journal:  Sci Rep       Date:  2022-07-11       Impact factor: 4.996

5.  Expression of Autophagic and Inflammatory Markers in Normal Mucosa of Individuals with Colorectal Adenomas: A Cross Sectional Study among Italian Outpatients Undergoing Colonoscopy.

Authors:  Paola Sena; Stefano Mancini; Monica Pedroni; Luca Reggiani Bonetti; Gianluca Carnevale; Luca Roncucci
Journal:  Int J Mol Sci       Date:  2022-05-06       Impact factor: 6.208

6.  Inhibition Effect of Chloroquine and Integrin-Linked Kinase Knockdown on Translation in Melanoma Cells.

Authors:  Dorota Gil; Piotr Laidler; Marta Zarzycka; Joanna Dulińska-Litewka
Journal:  Int J Mol Sci       Date:  2021-04-01       Impact factor: 5.923

Review 7.  Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions.

Authors:  Nuno Jorge Lamas; Arnaud Martel; Sacha Nahon-Estève; Samantha Goffinet; Adam Macocco; Corine Bertolotto; Sandra Lassalle; Paul Hofman
Journal:  Cancers (Basel)       Date:  2021-12-25       Impact factor: 6.639

8.  Autophagy-Related Chemoprotection against Sorafenib in Human Hepatocarcinoma: Role of FOXO3 Upregulation and Modulation by Regorafenib.

Authors:  Flavia Fondevila; Carolina Méndez-Blanco; Paula Fernández-Palanca; Tania Payo-Serafín; Jos van Pelt; Chris Verslype; Javier González-Gallego; José L Mauriz
Journal:  Int J Mol Sci       Date:  2021-10-29       Impact factor: 5.923

9.  Schisandrin B Induced ROS-Mediated Autophagy and Th1/Th2 Imbalance via Selenoproteins in Hepa1-6 Cells.

Authors:  Siran Tan; Zhi Zheng; Tianqi Liu; Xiaoyun Yao; Miao Yu; Yubin Ji
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 8.786

Review 10.  Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies.

Authors:  Minru Liao; Rui Qin; Wei Huang; Hong-Ping Zhu; Fu Peng; Bo Han; Bo Liu
Journal:  J Hematol Oncol       Date:  2022-04-12       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.